NCT00364819View on ClinicalTrials.gov

Initial Study of Rituximab to Treat Primary Biliary Cirrhosis

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

July 31, 2009

Study Completion Date

December 31, 2009

Conditions

Primary Biliary Cirrhosis

Interventions

DRUG

rituximab

rituximab 1000 mg IV day 1 and 15, given over 5 - 6 hours

Trial Locations (1)

95817

University of California Davis Medical Center, Sacramento

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

University of California, Davis

OTHER